140 related articles for article (PubMed ID: 30583764)
1. Antihistamine use and risk of ovarian cancer: A population-based case-control study.
Verdoodt F; Pottegård A; Dehlendorff C; Jäättelä M; Hallas J; Friis S; Kjaer SK
Maturitas; 2019 Feb; 120():47-52. PubMed ID: 30583764
[TBL] [Abstract][Full Text] [Related]
2. Drugs with potential chemopreventive properties in relation to epithelial ovarian cancer--a nationwide case-control study.
Baandrup L
Dan Med J; 2015 Jul; 62(7):. PubMed ID: 26183052
[TBL] [Abstract][Full Text] [Related]
3. Low-dose aspirin use and the risk of ovarian cancer in Denmark.
Baandrup L; Kjaer SK; Olsen JH; Dehlendorff C; Friis S
Ann Oncol; 2015 Apr; 26(4):787-792. PubMed ID: 25538177
[TBL] [Abstract][Full Text] [Related]
4. Statin use and risk for ovarian cancer: a Danish nationwide case-control study.
Baandrup L; Dehlendorff C; Friis S; Olsen JH; Kjær SK
Br J Cancer; 2015 Jan; 112(1):157-61. PubMed ID: 25393364
[TBL] [Abstract][Full Text] [Related]
5. Tubal ligation and salpingectomy and the risk of epithelial ovarian cancer and borderline ovarian tumors: a nationwide case-control study.
Madsen C; Baandrup L; Dehlendorff C; Kjaer SK
Acta Obstet Gynecol Scand; 2015 Jan; 94(1):86-94. PubMed ID: 25256594
[TBL] [Abstract][Full Text] [Related]
6. Prescription use of paracetamol and risk for ovarian cancer in Denmark.
Baandrup L; Friis S; Dehlendorff C; Andersen KK; Olsen JH; Kjaer SK
J Natl Cancer Inst; 2014 Jun; 106(6):dju111. PubMed ID: 24848623
[TBL] [Abstract][Full Text] [Related]
7. The association of reproductive factors with risk of non-epithelial ovarian cancer and comparison with serous ovarian cancer.
Hemmingsen CH; Kjaer SK; Bennetsen AKK; Dehlendorff C; Baandrup L
Gynecol Oncol; 2021 Aug; 162(2):469-474. PubMed ID: 34016454
[TBL] [Abstract][Full Text] [Related]
8. The Association Between Talc Use and Ovarian Cancer: A Retrospective Case-Control Study in Two US States.
Cramer DW; Vitonis AF; Terry KL; Welch WR; Titus LJ
Epidemiology; 2016 May; 27(3):334-46. PubMed ID: 26689397
[TBL] [Abstract][Full Text] [Related]
9. Antihistamines and Ovarian Cancer Survival: Nationwide Cohort Study and in Vitro Cell Viability Assay.
Verdoodt F; Dehlendorff C; Jäättelä M; Strauss R; Pottegård A; Hallas J; Friis S; Kjaer SK
J Natl Cancer Inst; 2020 Sep; 112(9):964-967. PubMed ID: 31688928
[TBL] [Abstract][Full Text] [Related]
10. Use of antidepressants and risk of epithelial ovarian cancer.
Mørch LS; Dehlendorff C; Baandrup L; Friis S; Kjaer SK
Int J Cancer; 2017 Dec; 141(11):2197-2203. PubMed ID: 28791695
[TBL] [Abstract][Full Text] [Related]
11. Hysterectomy and risk of epithelial ovarian cancer by histologic type, endometriosis, and menopausal hormone therapy.
Ring LL; Baandrup L; Zheng G; Gottschau M; Dehlendorff C; Mellemkjær L; Kjaer SK
Cancer Epidemiol; 2023 Jun; 84():102359. PubMed ID: 37054550
[TBL] [Abstract][Full Text] [Related]
12. Comparison of stage III mucinous and serous ovarian cancer: a case-control study.
Firat Cuylan Z; Karabuk E; Oz M; Turan AT; Meydanli MM; Taskin S; Sari ME; Sahin H; Ulukent SC; Akbayir O; Gungorduk K; Gungor T; Kose MF; Ayhan A
J Ovarian Res; 2018 Oct; 11(1):91. PubMed ID: 30376858
[TBL] [Abstract][Full Text] [Related]
13. Alcohol consumption and the risk of mucinous and nonmucinous epithelial ovarian cancer.
Modugno F; Ness RB; Allen GO
Obstet Gynecol; 2003 Dec; 102(6):1336-43. PubMed ID: 14662224
[TBL] [Abstract][Full Text] [Related]
14. Pelvic inflammatory disease and risk of epithelial ovarian cancer: a national population-based case-control study in Sweden.
Jonsson S; Jonsson H; Lundin E; Häggström C; Idahl A
Am J Obstet Gynecol; 2024 Jan; 230(1):75.e1-75.e15. PubMed ID: 37778677
[TBL] [Abstract][Full Text] [Related]
15. Alcohol consumption and ovarian cancer risk in a population-based case-control study.
Peterson NB; Trentham-Dietz A; Newcomb PA; Chen Z; Hampton JM; Willett WC; Egan KM
Int J Cancer; 2006 Nov; 119(10):2423-7. PubMed ID: 16921486
[TBL] [Abstract][Full Text] [Related]
16. Prolactin and Risk of Epithelial Ovarian Cancer.
Hathaway CA; Rice MS; Townsend MK; Hankinson SE; Arslan AA; Buring JE; Hallmans G; Idahl A; Kubzansky LD; Lee IM; Lundin EA; Sluss PM; Zeleniuch-Jacquotte A; Tworoger SS
Cancer Epidemiol Biomarkers Prev; 2021 Sep; 30(9):1652-1659. PubMed ID: 34244157
[TBL] [Abstract][Full Text] [Related]
17. Paracetamol use and risk of epithelial ovarian cancer: A nationwide nested case-control study.
Zheng G; Faber MT; Baandrup L; Kjaer SK
BJOG; 2024 Feb; 131(3):290-299. PubMed ID: 37551038
[TBL] [Abstract][Full Text] [Related]
18. A prospective study of leisure-time physical activity and risk of incident epithelial ovarian cancer: Impact by menopausal status.
Huang T; Eliassen AH; Hankinson SE; Okereke OI; Kubzansky LD; Wang M; Poole EM; Chavarro JE; Tworoger SS
Int J Cancer; 2016 Feb; 138(4):843-52. PubMed ID: 26335147
[TBL] [Abstract][Full Text] [Related]
19. Use of analgesic drugs and risk of ovarian cancer: results from a Danish case-control study.
Ammundsen HB; Faber MT; Jensen A; Høgdall E; Blaakaer J; Høgdall C; Kjaer SK
Acta Obstet Gynecol Scand; 2012 Sep; 91(9):1094-102. PubMed ID: 22646488
[TBL] [Abstract][Full Text] [Related]
20. Menopausal hormone therapy treatment options and ovarian cancer risk: A Swedish prospective population-based matched-cohort study.
Simin J; Tamimi RM; Callens S; Engstrand L; Brusselaers N
Int J Cancer; 2020 Jul; 147(1):33-44. PubMed ID: 31584190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
